AI-Driven Age Reversal Research Gains Momentum in Biotechnology
The pursuit of age reversal has become a significant focus in the tech world, with artificial intelligence playing a crucial role in accelerating research. Harvard geneticist David Sinclair is at the forefront, arguing that aging is a loss of information rather than function, likening it to a software problem. AI is being used to simulate molecules and identify combinations that can reverse aging at the epigenetic level. Technologies such as CRISPR, Yamanaka factors, and cellular reprogramming are being explored to roll back biological age. Senolytics, a new class of drugs, target senescent cells, or 'zombie cells,' to extend healthspan and lifespan. Companies like Celularity are working on immune reinforcement to bolster aging bodies. 
